Moody's: Global drugmakers to bounce back this year

04/26/2013 | PharmaTimes (U.K.)

The global pharmaceutical market is poised to return to earnings growth this year as the patent cliff eases, according to a report from Moody's. Merger and acquisition deals will likely increase, but transactions will be in the small to midsize range. In the U.S., the regulatory pathway for biosimilars will get clearer, with potential regulatory applications this year, according to the report.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC